Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
NEJM Evid ; 1(5): EVIDctcs2200041, 2022 05.
Article in English | MEDLINE | ID: mdl-38319222

ABSTRACT

Antimalarial Research in the AmazonMany patients who receive treatment for vivax malaria in the Americas present with recurrent infection within six months after completing treatment. This raises an important question: Does higher-dose primaquine work better than the treatment currently used in the Americas to prevent recurrences? This Clinical Trial Case Study describes the behind-the-scenes story of a randomized trial to evaluate antimalarial treatment efficacy in the Brazilian Amazon.


Subject(s)
Antimalarials , Malaria, Vivax , Primaquine , Humans , Antimalarials/therapeutic use , Brazil/epidemiology , Malaria, Vivax/drug therapy , Malaria, Vivax/epidemiology , Malaria, Vivax/prevention & control , Primaquine/therapeutic use , Randomized Controlled Trials as Topic
SELECTION OF CITATIONS
SEARCH DETAIL